Quidel Corporation
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Quidel Corporation sits in the top decile of US sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count).
Quidel Corporation: 9 sponsored US clinical trials, none currently recruiting.
Quidel Corporation sponsors 9 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 8 completed. The most-studied condition in this pipeline is Borrelia; Infection, Burgdorferi (Erythema Chronicum Migrans), with 1 trials.
Top-decile sponsor footprint
Quidel Corporation ranks in the top decile of sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Indexed trials (enrollment closed)
9 total, page 1 of 1
Sofia 2 Lyme FIA Whole Blood Clinical Study
NCT03238274
QuickVue Influenza A + B Test Field Study
NCT03417869
"Solana™ Trichomonas Assay Field Study"
NCT02566447
Strep A FIA Field Study, Sofia
NCT02153008
Sofia hCG FIA Field Study
NCT01803113
Sofia RSV FIA Field Study
NCT01734668
Sofia Strep A FIA Field Study
NCT01494792
Strep A Fluorescent Immunoassay and Analyzer Field Study
NCT01441479
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
NCT01309568
How the Quidel Corporation archive is shaped
9 indexed studies, none listed as recruiting (0% open); 8 completed (89%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Borrelia; Infection, Burgdorferi (Erythema Chronicum Migrans) (1 trial), 3 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Quidel Corporation: archived-pipeline peers nationwide
Peers matched on 9 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Quidel Corporation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 9 archived trials
- 4D Molecular Therapeutics · 9 trials · 44% recruiting
- 9 Meters Biopharma · 9 trials · 0% recruiting
- Aadi Bioscience · 9 trials · 33% recruiting
- Ablynx, a Sanofi company · 9 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Quidel Corporation page
9 registered trials is a research-attention snapshot, not an endorsement of Quidel Corporation or any single study.
- None of Quidel Corporation's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Borrelia; Infection, Burgdorferi (Erythema Chronicum Migrans) is the condition Quidel Corporation studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Borrelia; Infection, Burgdorferi (Erythema Chronicum Migrans) trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Quidel Corporation pipeline card: 9 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.